Invited review: Prion‐like transmission and spreading of tau pathology

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · see citing works

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · see citing works

Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563 · see citing works

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492 · see citing works

A Century of Alzheimer's Disease

Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,106 · see citing works

Transmission and spreading of tauopathy in transgenic mouse brain

Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803 · see citing works

Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427 · see citing works

Tau is a candidate gene for chromosome 17 frontotemporal dementia

Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374 · see citing works

Propagation of Tau Misfolding from the Outside to the Inside of a Cell

Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252 · see citing works

100 years of Lewy pathology

Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190 · see citing works

Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms

Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,114 · see citing works

Trans-Synaptic Spread of Tau Pathology In Vivo

Liu, L., Drouet, V., Wu, J., Witter, M. P., Small, S. A., Clelland, C. L. T., & Duff, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031302 · Cited by 994 · see citing works

Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies

Sanders, D. W., Kaufman, S. K., DeVos, S. L., Sharma, A. M., Mirbaha, H., Li, A., Barker, S. J., Foley, A. C., Thorpe, J. R., Serpell, L. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.047 · Cited by 986 · see citing works

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1343-6 · Cited by 925 · see citing works

Structural and functional characterization of two alpha-synuclein strains

Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., Madiona, K., Oliéric, V., Böckmann, A., Meier, B. H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3575 · Cited by 890 · see citing works

Prion-like spreading of pathological α-synuclein in brain

Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M. A., & Hasegawa, M. (2013) · Brain · doi:10.1093/brain/awt037 · Cited by 867 · see citing works

Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds

Holmes, B. B., DeVos, S. L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., Ouidja, M. O., Brodsky, F. M., Marasa, J., Bagchi, D. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301440110 · Cited by 859 · see citing works

The pathological process underlying Alzheimer’s disease in individuals under thirty

Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812 · see citing works

Prion-like mechanisms in neurodegenerative diseases

Frost, B., & Diamond, M. I. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2786 · Cited by 776 · see citing works

Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls

Maruyama, M., Shimada, H., Suhara, T., Shinotoh, H., Ji, B., Maeda, J., Zhang, M.-R., Trojanowski, J. Q., Lee, V. M.-Y., Ono, M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.037 · Cited by 760 · see citing works

Brain homogenates from human tauopathies induce tau inclusions in mouse brain

Clavaguera, F., Akatsu, H., Fraser, G. M., Crowther, R. A., Frank, S., Hench, J., Probst, A., Winkler, D. T., Reichwald, J., Staufenbiel, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301175110 · Cited by 750 · see citing works

Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein

Allen, B., Ingram, E., Takao, M., Smith, M. J., Jakes, R., Virdee, K., Yoshida, H., Holzer, M., Craxton, M., Emson, P. C., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09340.2002 · Cited by 746 · see citing works

Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons

Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.057 · Cited by 680 · see citing works

Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy

Iba, M., Guo, J. L., McBride, J. D., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2642-12.2013 · Cited by 664 · see citing works

Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR

Heise, H., Hoyer, W., Becker, S., Andronesi, O. C., Riedel, D., & Baldus, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506109102 · Cited by 642 · see citing works

Physiological release of endogenous tau is stimulated by neuronal activity

Pooler, A. M., Phillips, E. C., Lau, D. H. W., Noble, W., & Hanger, D. P. (2013) · The EMBO Reports · doi:10.1038/embor.2013.15 · Cited by 642 · see citing works

Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles

Guo, J. L., & Lee, V. M.-Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209296 · Cited by 636 · see citing works

Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys

Recasens, A., Dehay, B., Bové, J., Carballo‐Carbajal, I., Doveró, S., Pérez‐Villalba, A., Fernagut, P., Blesa, J., Parent, A., Perier, C., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24066 · Cited by 629 · see citing works

Neuronal activity regulates extracellular tau in vivo

Yamada, K., Holth, J. K., Liao, F., Stewart, F. R., Mahan, T. E., Jiang, H., Cirrito, J. R., Patel, T. K., Hochgräfe, K., Mandelkow, E., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131685 · Cited by 574 · see citing works

Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis

Eisele, Y. S., Obermüller, U., Heilbronner, G., Baumann, F., Kaeser, S. A., Wolburg, H., Walker, L. C., Staufenbiel, M., Heikenwalder, M., & Jucker, M. (2010) · Science · doi:10.1126/science.1194516 · Cited by 568 · see citing works

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Guerrero-Munoz, M. J., Kiritoshi, T., Neugebauer, V., Jackson, G. R., & Kayed, R. (2012) · Scientific Reports · doi:10.1038/srep00700 · Cited by 502 · see citing works

Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies

Spillantini, M. G., Bird, T. D., & Ghetti, B. F. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00162.x · Cited by 475 · see citing works

A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

Ahmed, Z., Cooper, J., Murray, T. K., Garn, K., McNaughton, E., Clarke, H., Parhizkar, S., Ward, M. A., Cavallini, A., Jackson, S., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1254-6 · Cited by 460 · see citing works

The propagation of prion-like protein inclusions in neurodegenerative diseases

Goedert, M., Clavaguera, F., & Tolnay, M. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.04.003 · Cited by 451 · see citing works

Staging of Argyrophilic Grains: An Age-Associated Tauopathy

Saito, Y., Ruberu, N. N., Sawabe, M., Arai, T., Tanaka, N., Kakuta, Y., Yamanouchi, H., & Murayama, S. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.911 · Cited by 432 · see citing works

Evidence for Seeding of β-Amyloid by Intracerebral Infusion of Alzheimer Brain Extracts in β-Amyloid Precursor Protein-Transgenic Mice

Kane, M. D., Lipinski, W. J., Callahan, M. J., Bian, F., Durham, R. A., Schwarz, R. D., Roher, A. E., & Walker, L. C. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03606.2000 · Cited by 394 · see citing works

Prion-like acceleration of a synucleinopathy in a transgenic mouse model

Mougenot, A.-L. J., Nicot, S., Bencsik, A. A., Morignat, E., Verchère, J., Lakhdar, L., Legastelois, S., & Baron, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.022 · Cited by 375 · see citing works

Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein

Probst, A., Götz, J., Wiederhold, K., Tolnay, M., Mistl, C., Jaton, A., Hong, M., Ishihara, T., Lee, V., Trojanowski, J., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010051148 · Cited by 362 · see citing works

Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions

Stöhr, J., Watts, J. C., Mensinger, Z. L., Oehler, A., Grillo, S. K., DeArmond, S. J., Prusiner, S. B., & Giles, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206555109 · Cited by 359 · see citing works

<i>In Vivo</i> Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice

Yamada, K., Cirrito, J. R., Stewart, F. R., Jiang, H., Finn, M. B., Holmes, B. B., Binder, L. I., Mandelkow, E.-M., Diamond, M. I., Lee, V. M.-Y., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2569-11.2011 · Cited by 351 · see citing works

A nucleated assembly mechanism of Alzheimer paired helical filaments

Friedhoff, P., von Bergen�, M., Mandelkow�, E., Davies, P., & Mandelkow�, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15712 · Cited by 340 · see citing works

Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments

Spillantini, M. G., Goedert, M., Crowther, R. A., Murrell, J. R., Farlow, M. R., & Ghetti, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4113 · Cited by 334 · see citing works

Seeded Aggregation and Toxicity of α-Synuclein and Tau

Nonaka, T., Watanabe, S., Iwatsubo, T., & Hasegawa, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148460 · Cited by 330 · see citing works

Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice

Sacino, A. N., Brooks, M., Thomas, M. A., McKinney, A. B., Lee, S., Regenhardt, R. W., McGarvey, N. H., Ayers, J. I., Notterpek, L. M., Borchelt, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321785111 · Cited by 328 · see citing works

Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients

Watts, J. C., Condello, C., Stöhr, J., Oehler, A., Lee, J., DeArmond, S. J., Lannfelt, L., Ingelsson, M., Giles, K., & Prusiner, S. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408900111 · Cited by 279 · see citing works

Widespread cytoskeletal pathology characterizes corticobasal degeneration.

Feany, M. Β., & Dickson, D. W. (1995) · PubMed · Cited by 276 · see citing works

Argyrophilic Grain Disease Is a Sporadic 4-Repeat Tauopathy

Togo, T., Sahara, N., Yen, S.-H., Cookson, N., Ishizawa, T., Hutton, M., de Silva, R., Lees, A., & Dickson, D. W. (2002) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1093/jnen/61.6.547 · Cited by 273 · see citing works

Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET

Okamura, N., Furumoto, S., Fodero‐Tavoletti, M. T., Mulligan, R. S., Harada, R., Yates, P. A., Pejoska, S., Kudo, Y., Masters, C. L., Yanai, K., et al. (2014) · Brain · doi:10.1093/brain/awu064 · Cited by 266 · see citing works

Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies

Dujardin, S., Lécolle, K., Caillierez, R., Bégard, S., Zommer, N., Lachaud, C., Carrier, S., Dufour, N., Aurégan, G., Winderickx, J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-14 · Cited by 259 · see citing works

Abnormal Tau proteins in progressive supranuclear palsy

Flament, S., Delacourte, A., Verny, M., Hauw, J., & Javoy-Agid, F. (1991) · Acta Neuropathologica · doi:10.1007/bf00296367 · Cited by 241 · see citing works

Specific Pathological Tau Protein Variants Characterize Pickʼs Disease

Delacourte, A., Robitaille, Y., Sergeant, N., Buée, L., Hof, P. R., Wattez, A., Laroche-Cholette, A., Mathieu, J., Chagnon, P., & Gauvreau, D. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199602000-00004 · Cited by 224 · see citing works

Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change

Frost, B., Ollesch, J., Wille, H., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805627200 · Cited by 224 · see citing works

Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein

Dujardin, S., Bégard, S., Caillierez, R., Lachaud, C., Delattre, L., Carrier, S., Loyens, A., Galas, M., Bousset, L., Melki, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100760 · Cited by 215 · see citing works

Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice

Peeraer, E., Bottelbergs, A., Van Kolen, K., Stancu, I.-C., Vasconcelos, B., Mahieu, M., Duytschaever, H., Ver Donck, L., Torremans, A., Sluydts, E., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.032 · Cited by 214 · see citing works

A highly selective and specific PET tracer for imaging of tau pathologies

Zhang, W., Arteaga, J., Cashion, D. K., Chen, G., Gangadharmath, U., Gomez, L. F., Kasi, D., Lam, C., Liang, Q., Liu, C., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120712 · Cited by 195 · see citing works

Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue

Yamada, T., McGeer, P. L., & McGeer, E. G. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90145-w · Cited by 192 · see citing works

Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment

Probst, A., Tolnay, M., Langui, D., Goedert, M., & Spillantini, M. G. (1996) · Acta Neuropathologica · doi:10.1007/s004010050565 · Cited by 188 · see citing works

Abnormal Tau-Containing Filaments in Neurodegenerative Diseases

Crowther, R. A., & Goedert, M. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4270 · Cited by 185 · see citing works

Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration.

Ksiȩżak-Reding, H., Morgan, K., Mattiace, L. A., Davies, P., Liu, W. K., Yen, S. H., Weidenheim, K. M., & Dickson, D. W. (1994) · PubMed Central · Cited by 184 · see citing works

Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice

Stöhr, J., Condello, C., Watts, J. C., Bloch, L., Oehler, A., Nick, M., DeArmond, S. J., Giles, K., DeGrado, W. F., & Prusiner, S. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408968111 · Cited by 173 · see citing works

Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy

Komori, T., Arai, N., Oda, M., Nakayama, H., Mori, H., Yagishita, S., Takahashi, T., Amano, N., Murayama, S., Murakami, S., et al. (1998) · Acta Neuropathologica · doi:10.1007/s004010050911 · Cited by 162 · see citing works

Argyrophilic grain disease: A late‐onset dementia with distinctive features among tauopathies

Tolnay, M., & Clavaguera, F. (2004) · Neuropathology · doi:10.1111/j.1440-1789.2004.00591.x · Cited by 150 · see citing works

Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans

Kraemer, B. C., Burgess, J. K., Chen, J. H., Thomas, J. H., & Schellenberg, G. D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl067 · Cited by 150 · see citing works

Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice

Clavaguera, F., Hench, J., Lavenir, I., Schweighauser, G., Frank, S., Goedert, M., & Tolnay, M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1231-5 · Cited by 143 · see citing works

Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes

Santa‐María, I., Varghese, M., Ksiȩżak-Reding, H., Dzhun, A., Wang, J., & Pasinetti, G. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323279 · Cited by 140 · see citing works

Seeded strain‐like transmission of β‐amyloid morphotypes in APP transgenic mice

Heilbronner, G., Eisele, Y. S., Langer, F., Kaeser, S. A., Novotny, R., Nagarathinam, A., Åslund, A., Hammarström, P., Nilsson, K. P. R., & Jucker, M. (2013) · EMBO Reports · doi:10.1038/embor.2013.137 · Cited by 139 · see citing works

“Prion‐Like” Templated Misfolding in Tauopathies

Clavaguera, F., Lavenir, I., Falcon, B., Frank, S., Goedert, M., & Tolnay, M. (2013) · Brain Pathology · doi:10.1111/bpa.12044 · Cited by 129 · see citing works

Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy

Nishimura, M., Namba, Y., Ikeda, K., & Oda, M. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90227-x · Cited by 120 · see citing works

SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans

Guthrie, C. R., Schellenberg, G. D., & Kraemer, B. C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp099 · Cited by 116 · see citing works

Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles

Probst, A., Langui, D., Lautenschläger, C., ULRICH, J., Brion, J., & Anderton, B. H. (1988) · Acta Neuropathologica · doi:10.1007/bf00688244 · Cited by 115 · see citing works

Zinc Binding Directly Regulates Tau Toxicity Independent of Tau Hyperphosphorylation

Huang, Y., Wu, Z., Cao, Y., Lang, M., Lu, B., & Zhou, B. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.047 · Cited by 114 · see citing works

Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease

Botez, G., Probst, A., Ipsen, S., & Tolnay, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010051077 · Cited by 96 · see citing works

Multiple Factors Contribute to the Peripheral Induction of Cerebral -Amyloidosis

Eisele, Y. S., Fritschi, S. K., Hamaguchi, T., Obermüller, U., Füger, P., Skodras, A., Schafer, C., Odenthal, J., Heikenwälder, M. F., Staufenbiel, M., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1608-14.2014 · Cited by 93 · see citing works

Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms

Tolnay, M., Sergeant, N., Ghestem, A., Chalbot, S., de Vos, R. A., Jansen Steur, E. N., Probst, A., & Delacourte, A. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0591-z · Cited by 89 · see citing works

Dopamine D2 Receptor Antagonism Suppresses Tau Aggregation and Neurotoxicity

McCormick, A. V., Wheeler, J. M., Guthrie, C. R., Liachko, N. F., & Kraemer, B. C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.027 · Cited by 64 · see citing works

MSUT2 is a determinant of susceptibility to tau neurotoxicity

Guthrie, C. R., Greenup, L., Leverenz, J. B., & Kraemer, B. C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr079 · Cited by 64 · see citing works

Spreading of a Prion Domain from Cell-to-Cell by Vesicular Transport in Caenorhabditis elegans

Nussbaum-Krammer, C. I., Park, K.-W., Li, L., Melki, R., & Morimoto, R. I. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003351 · Cited by 58 · see citing works

Quantitative analysis of neurofibrillary pathology in a general population to reappraise neuropathological criteria for senile dementia of the neurofibrillary tangle type (tangle‐only dementia): The Hisayama study

Noda, K., Sasaki, K., Fujimi, K., Wakisaka, Y., Tanizaki, Y., Wakugawa, Y., Kiyohara, Y., Iida, M., Aizawa, H., & Iwaki, T. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00722.x · Cited by 49 · see citing works

Frontotemporal lobar degeneration – tau as a pied piper?

Tolnay, M., & Probst, A. (2002) · Neurogenetics · doi:10.1007/s10048-002-0140-x · Cited by 42 · see citing works

The role of MSUT-2 in tau neurotoxicity: a target for neuroprotection in tauopathy?

Wheeler, J. M., Guthrie, C. R., & Kraemer, B. C. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380973 · Cited by 14 · see citing works

Frontotemporal Dementias

(2011) · KARGER eBooks · doi:10.1159/isbn.978-3-8055-9593-3 · Cited by 2 · see citing works

Neuronal Cell Death

Fricker, M., Tolkovsky, A. M., Borutaitė, V., Coleman, M. P., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,122 · see citing works

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy

Sengupta, U., Nilson, A. N., & Kayed, R. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.035 · Cited by 740 · see citing works

Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model

Harrison, I. F., Ismail, O., Machhada, A., Colgan, N. C., Ohene, Y., Nahavandi, P., Ahmed, Z., Fisher, A., Meftah, S., Murray, T. K., et al. (2020) · Brain · doi:10.1093/brain/awaa179 · Cited by 663 · see citing works

Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight

Shi, Y., & Holtzman, D. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0051-1 · Cited by 595 · see citing works

The Neuropathology of Chronic Traumatic Encephalopathy

McKee, A. C., Stein, T. D., Kiernan, P. T., & Alvarez, V. E. (2015) · Brain Pathology · doi:10.1111/bpa.12248 · Cited by 585 · see citing works

Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy

Kondo, A., Shahpasand, K., Mannix, R., Qiu, J., Moncaster, J., Chen, C.-H., Yao, Y., Lin, Y.-M., Driver, J. A., Sun, Y., et al. (2015) · Nature · doi:10.1038/nature14658 · Cited by 445 · see citing works

Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier

Tryphena, K. P., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 418 · see citing works

What is the evidence that tau pathology spreads through prion-like propagation?

Mudher, A., Colin, M., Dujardin, S., Medina, M., Dewachter, I., Alavi Naini, S. M., Mandelkow, E.-M., Mandelkow, E., Buée, L., Goedert, M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0488-7 · Cited by 384 · see citing works

Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies

Mackenzie, I. R., & Neumann, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13588 · Cited by 374 · see citing works

Updated TDP-43 in Alzheimer’s disease staging scheme

Josephs, K. A., Murray, M. E., Whitwell, J. L., Tosakulwong, N., Weigand, S. D., Petrucelli, L., Liesinger, A. M., Petersen, R. C., Parisi, J. E., & Dickson, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1537-1 · Cited by 366 · see citing works

Tau-based therapies in neurodegeneration: opportunities and challenges

Li, C., & Götz, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.155 · Cited by 272 · see citing works

Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: The clinical impact on children and beyond

Calderón‐Garcidueñas, L., Leray, E., Heydarpour, P., Torres‐Jardón, R., & Reis, J. J. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.10.008 · Cited by 226 · see citing works

Four-repeat tauopathies

Rösler, T. W., Marvian, A. T., Brendel, M., Nykänen, N.-P., Höllerhage, M., Schwarz, S. C., Hopfner, F., Koeglsperger, T., Respondek, G., Schweyer, K., et al. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101644 · Cited by 219 · see citing works

Raman Spectroscopy: An Emerging Tool in Neurodegenerative Disease Research and Diagnosis

Devitt, G., Howard, K., Mudher, A. K., & Mahajan, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00413 · Cited by 208 · see citing works

ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule‐associated proteins

Ramkumar, A., Jong, B. Y., & Ori-McKenney, K. M. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24599 · Cited by 194 · see citing works

Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers

Quinn, J. P., Corbett, N. J., Kellett, K. A. B., & Hooper, N. M. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-170959 · Cited by 170 · see citing works

Alzheimer's disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview

Matěj, R., Tesař, A., & Rusina, R. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.08.005 · Cited by 158 · see citing works

Passive immunotherapies targeting Aβ and tau in Alzheimer's disease

Plotkin, S. S., & Cashman, N. R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105010 · Cited by 156 · see citing works

Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae

Albayram, Ö., Kondo, A., Mannix, R., Smith, C., Tsai, C.-Y., Li, C., Herbert, M. K., Qiu, J., Monuteaux, M. C., Driver, J. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01068-4 · Cited by 152 · see citing works

Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies

Stamelou, M., Respondek, G., Giagkou, N., Whitwell, J. L., Kovács, G. G., & Höglinger, G. U. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00541-5 · Cited by 143 · see citing works

Hyperphosphorylation determines both the spread and the morphology of tau pathology

Hu, W. H., Zhang, X., Tung, Y. C., Xie, S.-T., Liu, F., & Iqbal, K. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.014 · Cited by 131 · see citing works

The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease

Kokiko-Cochran, O. N., & Godbout, J. P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00672 · Cited by 128 · see citing works

Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo

Vergara, C., Houben, S., Suain, V., Yilmaz, Z., Decker, R. D., Dries, V. V., Boom, A., Mansour, S., Leroy, K., Ando, K., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1953-5 · Cited by 125 · see citing works

Prion-Like Mechanisms in Parkinson’s Disease

Ma, J., Gao, J., Wang, J., & Xie, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00552 · Cited by 124 · see citing works

Neuronal network disintegration: common pathways linking neurodegenerative diseases

Ahmed, R. M., Devenney, E. M., Irish, M., Ittner, A., Naismith, S., Ittner, L. M., Rohrer, J. D., Halliday, G. M., Eisen, A., Hodges, J. R., et al. (2016) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp-2014-308350 · Cited by 128 · see citing works

Prion-Like Propagation of Post-Translationally Modified Tau in Alzheimer’s Disease: A Hypothesis

Sonawane, S. K., & Chinnathambi, S. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1111-5 · Cited by 113 · see citing works

Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma

Chiasseu, M., Vargas, J. L. C., Destroismaisons, L., Velde, C. V., Leclerc, N. M., & Polo, A. D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3986-15.2016 · Cited by 105 · see citing works

PICALM and Alzheimer’s Disease: An Update and Perspectives

Ando, K., Nagaraj, S., Küçükali, F., de Fisenne, M.-A., Kosa, A.-C., Doeraene, E., Lopez Gutierrez, L., Brion, J.-P., & Leroy, K. (2022) · Cells · doi:10.3390/cells11243994 · Cited by 104 · see citing works

Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease

Zhang, H., Cao, Y., Ma, L., Wei, Y., & Li, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.707268 · Cited by 104 · see citing works

Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain

Ossenkoppele, R., Iaccarino, L., Schonhaut, D. R., Brown, J. A., Joie, R. L., O’Neil, J. P., Janabi, M., Baker, S. L., Kramer, J. H., Gorno‐Tempini, M., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101848 · Cited by 103 · see citing works

Extracellular Vesicles in Alzheimer’s Disease: Friends or Foes? Focus on Aβ-Vesicle Interaction

Joshi, P., Benussi, L., Furlan, R., Ghidoni, R., & Verderio, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16034800 · Cited by 95 · see citing works

The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer’s Disease

Dugger, B. N., Whiteside, C. M., Maarouf, C. L., Walker, D. G., Beach, T. G., Sue, L. I., Garcia, A., Dunckley, T. L., Meechoovet, B., Reiman, E. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150859 · Cited by 93 · see citing works

New Features about Tau Function and Dysfunction

Medina, M., Hernández, F., & Ávila, J. (2016) · Biomolecules · doi:10.3390/biom6020021 · Cited by 92 · see citing works

Molecular subtypes of Alzheimer’s disease

Fede, G. D., Catania, M., Maderna, E., Ghidoni, R., Benussi, L., Tonoli, E., Giaccone, G., Moda, F., Paterlini, A., Campagnani, I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21641-1 · Cited by 85 · see citing works

Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy

Malpetti, M., Passamonti, L., Rittman, T., Jones, P. S., Vázquez Rodríguez, P., Bevan‐Jones, W. R., Hong, Y. T., Fryer, T. D., Aigbirhio, F. I., O'Brien, J. T., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25911 · Cited by 83 · see citing works

Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules

Brunello, C. A., Yan, X., & Huttunen, H. J. (2016) · Scientific Reports · doi:10.1038/srep30498 · Cited by 83 · see citing works

Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau

Josephs, K. A. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.04.016 · Cited by 80 · see citing works

Current directions in tau research: Highlights from Tau 2020

Sexton, C. E., Snyder, H. M., Beher, D., Boxer, A. L., Brannelly, P., Brion, J., Buée, L., Cacace, A. M., Chételat, G., Citron, M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12452 · Cited by 78 · see citing works

The roles of intrinsic disorder-based liquid-liquid phase transitions in the “Dr. Jekyll–Mr. Hyde” behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration

Uversky, V. N. (2017) · Autophagy · doi:10.1080/15548627.2017.1384889 · Cited by 76 · see citing works

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies

Ferrer, I., Aguiló, M., Carmona, M., Andrés‐Benito, P., Torrejón-Escribano, B., Garcia‐Esparcia, P., & del Rı́o, J. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00112 · Cited by 76 · see citing works

Potential of the Antibody Against cis–Phosphorylated Tau in the Early Diagnosis, Treatment, and Prevention of Alzheimer Disease and Brain Injury

Lu, K. P., Kondo, A., Albayram, Ö., Herbert, M. K., Liu, H., & Zhou, X. Z. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2027 · Cited by 74 · see citing works

The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-β (Aβ) Peptide at the Oligomeric Stage

Wallin, C., Hiruma, Y., Wärmländer, S. K. T. S., Huvent, I., Jarvet, J., Abrahams, J. P., Gräslund, A., Lippens, G. M., & Luo, J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b13623 · Cited by 67 · see citing works

Prion-like mechanisms in Alzheimer disease

Walker, L. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00016-7 · Cited by 65 · see citing works

Models of Network Spread and Network Degeneration in Brain Disorders

Raj, A., & Powell, F. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.07.012 · Cited by 65 · see citing works

Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk

Kayed, R., Dettmer, U., & Lesné, S. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-201965 · Cited by 62 · see citing works

The ordered assembly of tau is the gain‐of‐toxic function that causes human tauopathies

Goedert, M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.09.001 · Cited by 62 · see citing works

Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner

Ferrer, I. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.07.004 · Cited by 62 · see citing works

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers

Sánchez‐Juan, P., Moreno–Grau, S., de Rojas, I., Hernández, I., Valero, S., Alegret, M., Montrreal, L., García‐González, P., Lage, C., López‐García, S., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00327 · Cited by 61 · see citing works

Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases

Walker, L. C. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034943 · Cited by 59 · see citing works

Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures

Croft, C. L., Wade, M. A., Kurbatskaya, K., Mastrandreas, P., Hughes, M. M., Phillips, E. C., Pooler, A. M., Perkinton, M. S., Hanger, D. P., & Noble, W. J. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.97 · Cited by 59 · see citing works

AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy

Ising, C., Gallardo, G., Leyns, C. E. G., Wong, C. H., Jiang, H., Stewart, F., Koscal, L. J., Roh, J., Robinson, G. O., Remolina Serrano, J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162125 · Cited by 57 · see citing works

Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks

Schumacher, J., Gunter, J. L., Przybelski, S. A., Jones, D. T., Graff‐Radford, J., Savica, R., Schwarz, C. G., Senjem, M. L., Jack, C. R., Lowe, V. J., et al. (2021) · Brain · doi:10.1093/brain/awab218 · Cited by 57 · see citing works

Targeting Alzheimer's disease with gene and cell therapies

Loera‐Valencia, R., Piras, A., Ismail, M.-A.-M., Manchanda, S., Eyjolfsdottir, H., Saido, T. C., Johansson, J., Eriksdotter, M., Winblad, B. G., & Nilsson, P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12759 · Cited by 57 · see citing works

Insight into the Structure of the “Unstructured” Tau Protein

Popov, K. I., Makepeace, K. A. T., Petrotchenko, E. V., Dokholyan, N. V., & Borchers, C. H. (2019) · Structure · doi:10.1016/j.str.2019.09.003 · Cited by 57 · see citing works

Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy

Ferrer, I., Andrés‐Benito, P., Zelaya, M. V., Aguirre, M. E. E., Carmona, M., Ausín, K., Lachén‐Montes, M., Fernández‐Irigoyen, J., Santamaría, E., & del Rı́o, J. A. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02122-9 · Cited by 57 · see citing works

Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans

Weisová, P., Cehlár, O., Škrabana, R., Žilková, M., Filipčík, P., Kováčech, B., Prčina, M., Wojčiaková, Ľ., Fialová, Ľ., Smolek, T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0770-y · Cited by 52 · see citing works

Prion‐like propagation as a pathogenic principle in frontotemporal dementia

Hock, E., & Polymenidou, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13668 · Cited by 51 · see citing works

Tau secretion is correlated to an increase of Golgi dynamics

Mohamed, N., Desjardins, A., & Leclerc, N. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178288 · Cited by 50 · see citing works

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies

Fuster-Matanzo, A., Hernández, F., & Ávila, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030645 · Cited by 48 · see citing works

Tau internalization: A complex step in tau propagation

Zhao, J., Wu, H., & Tang, X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101272 · Cited by 46 · see citing works

siRNA drug delivery across the blood–brain barrier in Alzheimer's disease

Sajid, M. I., Sheikh, F. S., Anis, F., Nasim, N., Sumbria, R. K., Nauli, S. M., & Tiwari, R. K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114968 · Cited by 45 · see citing works

Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment

Marx, G. A., Koenigsberg, D., McKenzie, A. T., Kauffman, J., Hanson, R. W., Whitney, K. R., Signaevsky, M., Prastawa, M. W., Iida, M. A., White, C. L., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01457-x · Cited by 43 · see citing works

The Prion-Like Behavior of Assembled Tau in Transgenic MicePreprint

Clavaguera, F., Tolnay, M., & Goedert, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024372 · Cited by 42 · see citing works

Progressive supranuclear palsy

Giagkou, N., Höglinger, G. U., & Stamelou, M. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.013 · Cited by 41 · see citing works

Interneurons in the human olfactory system in Alzheimer's disease

Saiz‐Sánchez, D., Flores‐Cuadrado, A., Úbeda‐Bañón, I., de la Rosa‐Prieto, C., & Martı́nez-Marcos, A. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.11.009 · Cited by 41 · see citing works

Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo

Vandermeeren, M., Borgers, M., Kolen, K. V., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180404 · Cited by 39 · see citing works

PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding

Soares, A. C., Ferreira, A., Mariën, J., Delay, C., Lee, E. B., Trojanowski, J. Q., Moechars, D., Annaert, W. G., & Muynck, L. D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100636 · Cited by 38 · see citing works

Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation

Novák, P., Cehlár, O., Škrabana, R., & Novák, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179942 · Cited by 36 · see citing works

Relevance of host tau in tau seeding and spreading in tauopathies

Ferrer, I., Zelaya, M. V., Aguiló, M., Carmona, M., López‐González, I., Andrés‐Benito, P., Lidón, L., Gavı́n, R., Garcia‐Esparcia, P., & del Rı́o, J. A. (2019) · Brain Pathology · doi:10.1111/bpa.12778 · Cited by 35 · see citing works

The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents

Canet, G., Zussy, C., Hernandez, C., Maurice, T., Desrumaux, C. M., & Givalois, L. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108398 · Cited by 33 · see citing works

Tau Aggregation Propensity Engrained in Its Solution State

Eschmann, N. A., Do, T. D., LaPointe, N. E., Shea, J., Feinstein, S. C., Bowers, M. T., & Han, S. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b08092 · Cited by 33 · see citing works

Chronic Rhinosinusitis and Alzheimer’s Disease—A Possible Role for the Nasal Microbiome in Causing Neurodegeneration in the Elderly

Harrass, S., Yi, C., & Chen, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011207 · Cited by 31 · see citing works

Tracking brain damage in progressive supranuclear palsy: a longitudinal MRI study

Agosta, F., Caso, F., Ječmenica‐Lukić, M., Petrović, I. N., Valsasina, P., Meani, A., Copetti, M., Kostić, V. S., & Filippi, M. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317443 · Cited by 30 · see citing works

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics

Ritter, A. R., & Cummings, J. L. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00186 · Cited by 29 · see citing works

Reassessment of Neuronal Tau Distribution in Adult Human Brain and Implications for Tau Pathobiology

Paterno, G., Bell, B. M., Gorion, K.-M. M., Prokop, S., & Giasson, B. I. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01394-9 · Cited by 28 · see citing works

The role of adenosine A2A receptors in Alzheimer's disease and tauopathies

Launay, A., Nebie, O., Shankara, J. V., Lebouvier, T., Buée, L., Faivre, É., & Blum, D. L. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109379 · Cited by 28 · see citing works

Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia

Jash, S., Banerjee, S., Cheng, S., Wang, B., Qiu, C., Kondo, A., Ernerudh, J., Zhou, X. Z., Lu, K. P., & Sharma, S. (2023) · Nature Communications · doi:10.1038/s41467-023-41144-6 · Cited by 26 · see citing works

Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice

Tallon, C., Bell, B. J., Sharma, A., Pal, A., Malvankar, M. M., Thomas, A. G., Yoo, S., Hollinger, K. R., Coleman, K., Wilkinson, E. L., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102066 · Cited by 26 · see citing works

Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease

Marei, H. E. S., Khan, M. U. A., & Hasan, A. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00504-2 · Cited by 26 · see citing works

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Kadamangudi, S., Marcatti, M., Zhang, W.-R., Fracassi, A., Kayed, R., Limon, A., & Taglialatela, G. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02839-2 · Cited by 25 · see citing works

Astrogliopathy in Tauopathies

Ferrer, I. (2018) · Neuroglia · doi:10.3390/neuroglia1010010 · Cited by 25 · see citing works

Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications

Shahpasand‐Kroner, H., Siddique, I. A., Malik, R., Linares, G. R., Ivanova, M. I., Ichida, J. K., Weil, T., Münch, J., Sánchez‐García, E., Klärner, F., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000654 · Cited by 25 · see citing works

Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation

Ossola, B., Zhao, C., Compston, A., Pluchino, S., Franklin, R. J. M., & Spillantini, M. G. (2015) · Glia · doi:10.1002/glia.22940 · Cited by 24 · see citing works

The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins

Rossi, M., Kai, H., Baiardi, S., Bartoletti‐Stella, A., Carlà, B., Zenesini, C., Capellari, S., Kitamoto, T., & Parchi, P. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0706-6 · Cited by 23 · see citing works

The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition

Eskandari-Sedighi, G., Daude, N., Gapeshina, H., Sanders, D. W., Kamali-Jamil, R., Yang, J., Shi, B., Wille, H., Ghetti, B., Diamond, M. I., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0215-7 · Cited by 22 · see citing works

Nanobiotechnology in Neurodegenerative Diseases

Jampílek, J., Kráľová, K., Novák, P., & Novák, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-30930-5_4 · Cited by 22 · see citing works

Molecular Insights into Cell Type-specific Roles in Alzheimer’s Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling

Qu, W., Canoll, P., & Hargus, G. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.006 · Cited by 22 · see citing works

Genetic Architecture of Primary Tauopathies

Gallo, D., Ruiz, A., & Sánchez‐Juan, P. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.022 · Cited by 22 · see citing works

Interactions between Microtubule-Associated Protein Tau (MAPT) and Small MoleculesPreprint

Rauch, J. N., Olson, S. H., & Gestwicki, J. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024034 · Cited by 22 · see citing works

Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective

Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 21 · see citing works

Tauopathies: Mechanisms and Therapeutic Strategies

Tan, C., Zhang, X.-Y., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170187 · Cited by 20 · see citing works

Amyloid-β (Aβ)-Related Cerebral Amyloid Angiopathy Causing Lobar Hemorrhage Decades After Childhood Neurosurgery

Kellie, J. F., Campbell, B. C. V., Watson, R., Praeger, A., Nair, G., Murugasu, A., Rowe, C. C., Masters, C. L., Collins, S. J., McLean, C., et al. (2022) · Stroke · doi:10.1161/strokeaha.121.038364 · Cited by 20 · see citing works

What amyloid ligands can tell us about molecular polymorphism and disease

LeVine, H., & Walker, L. C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.019 · Cited by 19 · see citing works

Targeting Prion-like Cis Phosphorylated Tau Pathology in Neurodegenerative Diseases

Albayram, Ö., Angeli, P. A., Bernstein, E. R., Baxley, S., Gao, Z. J., Lu, K. P., & Zhou, X. Z. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000443 · Cited by 19 · see citing works

pFTAA - a high affinity oligothiophene probe that detects filamentous tau in vivo and in cultured neurons

Tolkovsky, A. M., Brelstaff, J., & Spillantini, M. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.165298 · Cited by 18 · see citing works

Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects

Alyenbaawi, H., Allison, W. T., & Mok, S. (2020) · Biomolecules · doi:10.3390/biom10111487 · Cited by 18 · see citing works

Tauopathy in transgenic (SHR72) rats impairs function of central noradrenergic system and promotes neuroinflammation

Mravec, B., Lejavová, K., Vargovič, P., Ondičová, K., Horváthová, Ľ., Novák, P., Manz, G., Filipčík, P., Novák, M., & Květňanský, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0482-1 · Cited by 18 · see citing works

Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion

Espargaró, A., Busquets, M. A., Estelrich, J., & Sabaté, R. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00029 · Cited by 18 · see citing works

Olfactory function in neuropsychiatric disorders

Ryo, Y., Takeuchi, M., Ueda, N., Ohi, K., Kihara, H., Shimada, T., Uehara, T., & Kawasaki, Y. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.058 · Cited by 17 · see citing works

Distinct regulation of Tau Monomer and aggregate uptake and intracellular accumulation in human neurons

Marvian, A. T., Strauß, T., Tang, Q., Tuck, B. J., Keeling, S., Rüdiger, D., Dizaji, N. M., Mohammad‐Beigi, H., Nuscher, B., Chakraborty, P., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00786-w · Cited by 16 · see citing works

The Prion-Like Behavior of Assembled Tau in Transgenic MicePreprint

Clavaguera, F., Tolnay, M., & Goedert, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024372 · Cited by 42 · see citing works

“Prion‐Like” Templated Misfolding in Tauopathies

Clavaguera, F., Lavenir, I., Falcon, B., Frank, S., Goedert, M., & Tolnay, M. (2013) · Brain Pathology · doi:10.1111/bpa.12044 · Cited by 129 · see citing works

Prion-Like Properties of Assembled Tau Protein

Clavaguera, F., Tolnay, M., & Goedert, M. (2013) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-35491-5_7 · Cited by 1 · see citing works

Prion-like Spreading in Tauopathies

Ayers, J. I., Giasson, B. I., & Borchelt, D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.04.003 · Cited by 100 · see citing works

Prion-like characteristics of the microtubule-associated protein tau

Frost, S. E. (2009) · eScholarship (California Digital Library)